Yonesaka, K., Kudo, K., Nishida, S., Takahama, T., Iwasa, T., Yoshida, T., . . . Nakagawa, K. (2015). The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer. Oncotarget.
Chicago ZitierstilYonesaka, Kimio, et al. "The Pan-HER Family Tyrosine Kinase Inhibitor Afatinib Overcomes HER3 Ligand Heregulin-mediated Resistance to EGFR Inhibitors in Non-small Cell Lung Cancer." Oncotarget 2015.
MLA ZitierstilYonesaka, Kimio, et al. "The Pan-HER Family Tyrosine Kinase Inhibitor Afatinib Overcomes HER3 Ligand Heregulin-mediated Resistance to EGFR Inhibitors in Non-small Cell Lung Cancer." Oncotarget 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.